Nasal methicillin-resistant staphylococcus aureus carriage in tertiary hospitals: Evidence of hospitalacquired transmission in Nigeria

Methicillin-resistant staphylococcus aureus (MRSA) nasal carriage is a significant source of infection and transmission in hospital environments. Effective infection control and antimicrobial stewardship are hampered in low-and middleincome countries by a lack of local monitoring data. This study investigated the prevalence, antimicrobial resistance pattern and genetic determinants of MRSA in patients and healthcare in two tertiary hospitals in Nigerian. A total 1, 309 nasal swabs specimens were collected from in-patients, healthcare workers and out-patients from two different tertiary hospitals. Staphylococcus aureus was identified and isolated using standard biochemical methods. The MRSA were phenotypically detected using Brilliance MRSA chromagar and cefoxitin and latter subjected to antimicrobial susceptibility testing following the standard Kirby–Bauer disk diffusion method. PCR-specific primers were used to screen for mecA and pvl genes in ten randomly selected MRSA. Out of the 1,309 nasal samples collected, 575 S. aureus representing 43.9% were isolated from the nasal samples of which 96 (17%) were MRSA, 81 from in-patients/out-patients and 15 from health care workers. The in-patients and doctors habour the highest number of MRSA, 73/81 and 8/15 respectively. All the MRSA isolates resistant to cefoxitin were also found to be resistant to tetracycline, amoxicillin, and amoxicillin-clavulanic acid. The mecA and pvl genes were detected in five of the isolates. However, pvl gene was detected in one isolate without corresponding detection of mecA gene. The high frequency of MRSA carriage among patients and healthcare personnel underscores the potential for hospital-acquired transmission and highlights the need for strengthened infection control and antibiotic stewardship in Nigerian tertiary hospitals.

1. Chambers, Henry F., and Frank R. Deleo. ‘Waves of Resistance: Staphylococcus Aureus in the Antibiotic Era’. Nature Reviews. Microbiology 7, no. 9 (2009): 629–41. https://doi.org/10.1038/nrmicro2200.

2. Lowy, F. D. ‘Staphylococcus Aureus Infections’. The New England Journal of Medicine 339, no. 8 (1998): 520–32. https://doi.org/10.1056/NEJM199808203390806

3. Azzam, Ahmed, Heba Khaled, Heba Mohamed Fayed, et al. ‘Prevalence, Antibiogram, and Risk Factors of Methicillin-Resistant Staphylococcus Aureus (MRSA) Asymptomatic Carriage in Africa: A Systematic Review and Meta-Analysis’. BMC Infectious Diseases 25, no. 1 (2025): 505. https://doi.org/10.1186/s12879-025-10819-4.

4. Cosgrove, Sara E., George Sakoulas, Eli N. Perencevich, Mitchell J. Schwaber, Adolf W. Karchmer, and Yehuda Carmeli. ‘Comparison of Mortality Associated with Methicillin-Resistant and Methicillin-Susceptible Staphylococcus Aureus Bacteremia: A Meta-Analysis’. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 36, no. 1 (2003): 53–59. https://doi.org/10.1086/345476.

5. ‘WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance’. Accessed 4 November 2025. https://www.who.int/publications/i/item/9789240093461?utm_source=chatgpt.com.

6. Touaitia, Rahima, Assia Mairi, Nasir Adam Ibrahim, Nosiba S. Basher, Takfarinas Idres, and Abdelaziz Touati. ‘Staphylococcus Aureus: A Review of the Pathogenesis and Virulence Mechanisms’. Antibiotics 14, no. 5 (2025): 470. https://doi.org/10.3390/antibiotics14050470.

7. Eiff, C. von, K. Becker, K. Machka, H. Stammer, and G. Peters. ‘Nasal Carriage as a Source of Staphylococcus Aureus Bacteremia. Study Group’. The New England Journal of Medicine 344, no. 1 (2001): 11–16. https://doi.org/10.1056/NEJM200101043440102

8. Esther, James, Ogbonna Brian Onyebuchi, Onwuchuluba Ebele Eugenia, et al. ‘Antimicrobial Resistance in Nigeria’s Healthcare System: A Comprehensive Narrative Review and Policy Implications’. Discover Public Health 22, no. 1 (2025): 460. https://doi.org/10.1186/s12982-025-00859-1.

9. Antimicrobial Resistance’. Accessed 4 November 2025. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

10. Turner, Nicholas A., Batu K. Sharma-Kuinkel, Stacey A. Maskarinec, et al. ‘Methicillin-Resistant Staphylococcus Aureus: An Overview of Basic and Clinical Research’. Nature Reviews. Microbiology 17, no. 4 (2019): 203–18. https://doi.org/10.1038/s41579-018-0147-4

11. Cheesbrough, Monica. District Laboratory Practice in Tropical Countries. 2nd edn. Cambridge University Press, 2006. https://doi.org/10.1017/CBO9780511543470.

12. Ofokansi, K. C., M. U. Adikwu, C. O. Esimone, and Martina Nwodo. Indian Journal of Pharmaceutical Sciences. n.d. Accessed 7 November 2025. https://www.ijpsonline.com/.

13. Nawrot, Urszula, Katarzyna Wlodarczyk, Magdalena Wrobel, Anita Wasik, and Tadeusz Dobosz. ‘Comparison of the Utility of Five Commercial Kits for Extraction of DNA from Aspergillus Fumigatus Spores’. Acta Biochimica Polonica 57, no. 4 (2010): 567–71.

14. CLSI, 2012. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty–Second Information and Supplement M100 –S22-32. Wayne P. A. 62 – 78.

15. Luteijn, J. M., G. a. A. Hubben, P. Pechlivanoglou, M. J. Bonten, and M. J. Postma. ‘Diagnostic Accuracy of CultureBased and PCR-Based Detection Tests for Methicillin-Resistant Staphylococcus Aureus: A Meta-Analysis’. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 17, no. 2 (2011): 146–54. https://doi.org/10.1111/j.1469-0691.2010.03202.x.

16. ‘Comparing the Efficiency of Taq DNA Polymerase and PuRe Taq Ready-To-Go PCR Beads in Amplifying 12S and 16S Ribosomal Genes’. Accessed 7 November 2025. https://researcherslinks.com/current-issues/Comparing-the-efficiency-of/26/1/1891.

17. Laux, Claudia, Andreas Peschel, and Bernhard Krismer. ‘Staphylococcus Aureus Colonization of the Human Nose and Interaction with Other Microbiome Members’. Microbiology Spectrum 7, no. 2 (n.d.): 10.1128/microbiolspec.gpp3-0029–2018. https://doi.org/10.1128/microbiolspec.gpp3-0029-2018.

18. Castro, A., N. Komora, V. Ferreira, et al. ‘Prevalence of Staphylococcus Aureus from Nares and Hands on Health Care Professionals in a Portuguese Hospital’. Journal of Applied Microbiology 121, no. 3 (2016): 831–39. https://doi.org/10.1111/jam.13186.

19. Garoy, Eyob Yohaness, Yacob Berhane Gebreab, Oliver Okoth Achila, et al. ‘Methicillin-Resistant Staphylococcus Aureus (MRSA): Prevalence and Antimicrobial Sensitivity Pattern among Patients-A Multicenter Study in Asmara, Eritrea’. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale 2019 (2019): 8321834. https://doi.org/10.1155/2019/8321834.

20. Ec, Okonkwo, Orji Jo, Aondoackaa Ad, et al. ‘Prevalence and Antibiotic Sensitivity Pattern of Staphylococcus Aureus Isolates of Non-Hospital Origin’. Archives of Clinical Microbiology 9, no. 1 (2018). https://doi.org/10.4172/1989-8436.100076.

21. Prevalence and Antibiotic Susceptibility Pattern of Methicillin Resistant Staphylococcus Aureus in Burns and Pressure Ulcer Patients – Afrjcem.Org. 7 March 2019. https://afrjcem.org/prevalence-and-antibiotic-susceptibility-pattern-of-methicillin-resistantstaphylococcus-aureus-in-burns-and-pressure-ulcer-patients/.

22. Du, Jimei, Chun Chen, Baixing Ding, et al. ‘Molecular Characterization and Antimicrobial Susceptibility of Nasal Staphylococcus Aureus Isolates from a Chinese Medical College Campus’. PLOS ONE 6, no. 11 (2011): e27328. https://doi.org/10.1371/journal.pone.0027328.

23. Sam, I.-Ching, Maria Kahar-Bador, Yoke-Fun Chan, Shih-Keng Loong, and Fadzilah Mohd Nor Ghazali. ‘Multisensitive Community-Acquired Methicillin-Resistant Staphylococcus Aureus Infections in Malaysia’. Diagnostic Microbiology and Infectious Disease 62, no. 4 (2008): 437–39. https://doi.org/10.1016/j.diagmicrobio.2008.07.016.

24. Chen, Chih-Jung, Kuang-Hung Hsu, Tzou-Yien Lin, Kao-Pin Hwang, Po-Yen Chen, and Yhu-Chering Huang. ‘Factors Associated with Nasal Colonization of Methicillin-Resistant Staphylococcus Aureus among Healthy Children in Taiwan’. Journal of Clinical Microbiology 49, no. 1 (2011): 131–37. https://doi.org/10.1128/JCM.01774-10.

25. Braga, Eneida Dias Vianna, F bio Aguiar-Alves, Maria de F tima Nogueira de Freitas, et al. ‘High Prevalence of Staphylococcus Aureus and Methicillin-Resistant S. Aureuscolonization among Healthy Children Attending Public Daycare Centers in Informal Settlements in a Large Urban Center in Brazil’. BMC Infectious Diseases 14, no. 1 (2014): 538. https://doi.org/10.1186/1471-2334-14-538.

26. Denton, M., B. O’Connell, P. Bernard, V. Jarlier, Z. Williams, and A. Santerre Henriksen. ‘The EPISA Study: Antimicrobial Susceptibility of Staphylococcus Aureus Causing Primary or Secondary Skin and Soft Tissue Infections in the Community in France, the UK and Ireland’. The Journal of Antimicrobial Chemotherapy 61, no. 3 (2008): 586–88. https://doi.org/10.1093/jac/dkm531.

27. Taiwo, S. S., M. Bamidele, E. A. Omonigbehin, et al. ‘Molecular Epidemiology of Methicillin-Resistant Staphylococcus Aureus in Ilorin, Nigeria’. West African Journal of Medicine 24, no. 2 (2005): 100–106.

28. Methicilin-Resistant Staphylococcus Aureus (MRSA) at Jos University Teaching Hospital – Afrjcem.Org. 27 February 2019. https://afrjcem.org/methicilin-resistant-staphylococcusaureus-mrsa-at-jos-university-teaching-hospital/.

29. Udeani, T. K., C. J. Onyebuchi, M. C. Ikpenwa, and U. R. Ezenwaka. ‘Prevalence and Antibiotic Susceptibility Pattern of Methicillin Resistant Staphylococcus Aureus in Burns and Pressure Ulcer Patients’. African Journal of Clinical and Experimental Microbiology 17, no. 2 (2016): 130–39. https://doi.org/10.4314/ajcem.v17i2.9.

30. Nwankwo, Emmanuel Onwubiko, and Magaji Sadiq Nasiru. ‘Antibiotic Sensitivity Pattern of Staphylococcus Aureus from Clinical Isolates in a Tertiary Health Institution in Kano, Northwestern Nigeria’. The Pan African Medical Journal 8 (2011): 4. https://doi.org/10.4314/pamj.v8i1.71050.

31. Iyamba, Jean-Marie Liesse, Jos Mulwahali Wambale, Cyprien Mbundu Lukukula, and Ntondo za Balega TakaisiKikuni. ‘High Prevalence of Methicillin Resistant Staphylococci Strains Isolated from Surgical Site Infections in Kinshasa’. The Pan African Medical Journal 18 (2014): 322. https://doi.org/10.11604/pamj.2014.18.322.4440.

32. Khanal, Rita, Prakash Sah, Pramila Lamichhane, Apsana Lamsal, Sweety Upadhaya, and Vijay Kumar Pahwa. ‘Nasal Carriage of Methicillin Resistant Staphylococcus Aureus among Health Care Workers at a Tertiary Care Hospital in Western Nepal’. Antimicrobial Resistance and Infection Control 4, no. 1 (2015): 39. https://doi.org/10.1186/s13756-015-0082-3.

33. Saravolatz, Louis, Joan Pawlak, and Leonard Johnson. ‘In Vitro Activity of Ceftaroline against Community-Associated Methicillin-Resistant, Vancomycin-Intermediate, VancomycinResistant, and Daptomycin-Nonsusceptible Staphylococcus Aureus Isolates’. Antimicrobial Agents and Chemotherapy 54, no. 7 (2010): 3027–30. https://doi.org/10.1128/AAC.01516-09.

34. Llarrull, Leticia I., Jed F. Fisher, and Shahriar Mobashery. ‘Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus Aureus and Insights into New -Lactams That Meet the Challenge’. Antimicrobial Agents and Chemotherapy 53, no. 10 (2009): 4051–63. https://doi.org/10.1128/AAC.00084-09.

35. Abdullahi, N. and Iregbu, K.C. (2008). Methicillin resisitant Staphylococcus aureus (MRSA) in a Central Nigerian Tertiarly Hospital. Ann.Trop. Pathol, 9: 6 -10.

36. ‘Prevalence of Methicillin-Resistant S. Aureus (MRSA) among Apparently Healthy Students in Afikpo, Ebonyi State, Nigeria’. Issues in Biological Sciences and Pharmaceutical Research, Journal Issues, January 2015. https://journalissues.org/ibspr/abstract/iroha-et-al-january-2015/.

37. Benoit, Stephen R., Concepci n Estivariz, Cristina Mogdasy, et al. ‘Community Strains of Methicillin-Resistant Staphylococcus Aureus as Potential Cause of Healthcare-Associated Infections, Uruguay, 2002-2004’. Emerging Infectious Diseases 14, no. 8 (2008): 1216–23. https://doi.org/10.3201/eid1408.071183.

38. Chambers, Henry F., and Frank R. Deleo. ‘Waves of Resistance: Staphylococcus Aureus in the Antibiotic Era’. Nature Reviews. Microbiology 7, no. 9 (2009): 629–41. https://doi.org/10.1038/nrmicro2200.

39. Funaki, Toshitaka, Tsutomu Yasuhara, Satoshi Kugawa, et al. ‘SCCMec Typing of PVL-Positive Community-Acquired Staphylococcus Aureus (CA-MRSA) at a Japanese Hospital’. Heliyon 5, no. 3 (2019): e01415. https://doi.org/10.1016/j.heliyon.2019.e01415.